Skip to main content

Advertisement

Log in

Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose

To determine the nature and severity of vasomotor symptoms, sexual problems, mood and sleep disturbance in community-dwelling breast cancer patients, whether and where they received treatment for these symptoms and their satisfaction with treatment received.

Methods

Online cross-sectional survey distributed through Breast Cancer Network Australia (BCNA).

Results

524/2286 women responded to the invitation to participate. Of these, 74% (385/523) reported symptoms of interest and were included in the analysis. Mean age was 55.2 years and mean time since breast cancer diagnosis was 5.7 years. Most (66%) had received chemotherapy and were taking endocrine therapy (64%). The most common symptoms were hot flushes/night sweats and sleep disturbance (both 89%), vaginal dryness (75%), mood swings (62%) and sexual problems (60%). Symptoms were mild (21–33%) or moderate (21–38%) in around one third and severe in up to one quarter (8–26%). Symptoms affected the ability to “get on with their life” for 36%, predicted by severity of hot flushes (OR 1.4), sleep disturbance (OR 1.3), mood disturbance (OR 1.3), and sexual problems (OR 1.3). Only 32% were offered treatment, mostly delivered by GPs (33%) or oncologists (26%). Only 49% found this “somewhat effective” and 34% found it ineffective. The majority (60%) wanted more support to manage their symptoms.

Conclusion

Menopausal symptoms, sexual problems, mood and sleep difficulties are common after breast cancer and often not effectively managed. There is an unmet need for coordinated care providing effective treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Davis SR, Panjari M, Robinson PJ, Fradkin P, Bell RJ (2014) Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis. Menopause 21(10):1075–1081. https://doi.org/10.1097/GME.0000000000000219

    Article  PubMed  Google Scholar 

  2. Marino JL, Hickey M, Saunders CM, Emery LI, Green H, Doherty DA (2014) Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history. Menopause 21(3):267–274. https://doi.org/10.1097/GME.0b013e3182976f46

    Article  PubMed  Google Scholar 

  3. Kenyon M, Mayer DK, Owens AK (2014) Late and long-term effects of breast cancer treatment and surveillance management for the general practitioner. J Obstet Gynecol Neonatal Nurs 43(3):382–398. https://doi.org/10.1111/1552-6909.12300

    Article  PubMed  Google Scholar 

  4. Yi M, Hwang E (2018) Pain and menopause symptoms of breast cancer patients with adjuvant hormonal therapy in Korea: secondary analysis. Asia Pac J Oncol Nurs 5(3):262–269. https://doi.org/10.4103/apjon.apjon_45_17

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yamamoto S, Masutani E, Arao H (2016) Effect of persistent menopausal symptoms on the wellbeing of Japanese breast cancer survivors. Nurs Health Sci 18(3):379–386. https://doi.org/10.1111/nhs.12283

    Article  PubMed  Google Scholar 

  6. Carpenter JS, Andrykowski MA (1999) Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum 26(8):1311–1317

    CAS  PubMed  Google Scholar 

  7. Smith SG, Sestak I, Howell A, Forbes J, Cuzick J (2017) Participant-reported symptoms and their effect on long-term adherence in the International Breast Cancer Intervention Study I (IBIS I). J Clin Oncol 35(23):2666–2673. https://doi.org/10.1200/jco.2016.71.7439

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Holmberg L, Anderson H (2004) HABITS (hormonal replacement therapy after breast cancer–is it safe?), a randomised comparison: trial stopped. Lancet 363(9407):453–455. https://doi.org/10.1016/s0140-6736(04)15493-7

    Article  CAS  PubMed  Google Scholar 

  9. Kenemans P, Bundred NJ, Foidart JM, Kubista E, von Schoultz B, Sismondi P, Vassilopoulou-Sellin R, Yip CH, Egberts J, Mol-Arts M, Mulder R, van Os S, Beckmann MW (2009) Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 10(2):135–146. https://doi.org/10.1016/s1470-2045(08)70341-3

    Article  CAS  PubMed  Google Scholar 

  10. Grant MD, Marbella A, Wang AT, Pines E, Hoag J, Bonnell C, Ziegler KM, Aronson N (2015) Menopausal symptoms: comparative effectiveness of therapies. AHRQ comparative effectiveness reviews. Agency for Healthcare Research and Quality (US), Rockville

    Google Scholar 

  11. Biglia N, Cozzarella M, Cacciari F, Ponzone R, Roagna R, Maggiorotto F, Sismondi P (2003) Menopause after breast cancer: a survey on breast cancer survivors. Maturitas 45(1):29–38. https://doi.org/10.1016/S0378-5122(03)00087-2

    Article  PubMed  Google Scholar 

  12. Hickey M, Szabo RA, Hunter MS (2017) Non-hormonal treatments for menopausal symptoms. BMJ 359:j5101. https://doi.org/10.1136/bmj.j5101

    Article  PubMed  Google Scholar 

  13. Hummel SB, van Lankveld J, Oldenburg HSA, Hahn DEE, Kieffer JM, Gerritsma MA, Kuenen MA, Bijker N, Borgstein PJ, Heuff G, Lopes Cardozo AMF, Plaisier PW, Rijna H, van der Meij S, van Dulken EJ, Vrouenraets BC, Broomans E, Aaronson NK (2017) Efficacy of internet-based cognitive behavioral therapy in improving sexual functioning of breast cancer survivors: results of a randomized controlled trial. J Clin Oncol 35(12):1328–1340. https://doi.org/10.1200/jco.2016.69.6021

    Article  PubMed  Google Scholar 

  14. Green SM, Donegan E, Frey BN, Fedorkow DM, Key BL, Streiner DL, McCabe RE (2019) Cognitive behavior therapy for menopausal symptoms (CBT-Meno): a randomized controlled trial. Menopause. https://doi.org/10.1097/gme.0000000000001363

    Article  PubMed  Google Scholar 

  15. McCurry SM, Guthrie KA, Morin CM, Woods NF, Landis CA, Ensrud KE, Larson JC, Joffe H, Cohen LS, Hunt JR, Newton KM, Otte JL, Reed SD, Sternfeld B, Tinker LF, LaCroix AZ (2016) Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: a MsFLASH randomized clinical trial. JAMA Intern Med 176(7):913–920. https://doi.org/10.1001/jamainternmed.2016.1795

    Article  PubMed  PubMed Central  Google Scholar 

  16. Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant HE, Bundred NJ, Burchell JM, Campbell AM, Carroll JS, Clarke RB, Coles CE, Cook GJ, Cox A, Curtin NJ, Dekker LV, Silva Idos S, Duffy SW, Easton DF, Eccles DM, Edwards DR, Edwards J, Evans D, Fenlon DF, Flanagan JM, Foster C, Gallagher WM, Garcia-Closas M, Gee JM, Gescher AJ, Goh V, Groves AM, Harvey AJ, Harvie M, Hennessy BT, Hiscox S, Holen I, Howell SJ, Howell A, Hubbard G, Hulbert-Williams N, Hunter MS, Jasani B, Jones LJ, Key TJ, Kirwan CC, Kong A, Kunkler IH, Langdon SP, Leach MO, Mann DJ, Marshall JF, Martin L, Martin SG, Macdougall JE, Miles DW, Miller WR, Morris JR, Moss SM, Mullan P, Natrajan R, O’Connor JP, O’Connor R, Palmieri C, Pharoah PD, Rakha EA, Reed E, Robinson SP, Sahai E, Saxton JM, Schmid P, Smalley MJ, Speirs V, Stein R, Stingl J, Streuli CH, Tutt AN, Velikova G, Walker RA, Watson CJ, Williams KJ, Young LS, Thompson AM (2013) Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res 15(5):R92. https://doi.org/10.1186/bcr3493

    Article  PubMed  PubMed Central  Google Scholar 

  17. Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T, Paterson I (2006) Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 9(1):49–58. https://doi.org/10.1080/13697130500487224

    Article  CAS  PubMed  Google Scholar 

  18. Palacios S, Henderson VW, Siseles N, Tan D, Villaseca P (2010) Age of menopause and impact of climacteric symptoms by geographical region. Climacteric 13(5):419–428. https://doi.org/10.3109/13697137.2010.507886

    Article  CAS  PubMed  Google Scholar 

  19. Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77–101. https://doi.org/10.1191/1478088706qp063oa

    Article  Google Scholar 

  20. Hickey M, Emery LI, Gregson J, Doherty DA, Saunders CM (2010) The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care. Menopause 17(4):727–733. https://doi.org/10.1097/gme.0b013e3181d672f6

    Article  PubMed  Google Scholar 

  21. Seib C, Porter-Steele J, McGuire A, McCarthy A, Balaam S, Anderson DJ (2017) Menopausal symptom clusters and their correlates in women with and without a history of breast cancer: a pooled data analysis from the Women’s Wellness Research Program. Menopause 24:624–634. https://doi.org/10.1097/GME.0000000000000810

    Article  PubMed  Google Scholar 

  22. Harris PF, Remington PL, Trentham-Dietz A, Allen CI, Newcomb PA (2002) Prevalence and treatment of menopausal symptoms among breast cancer survivors. J Pain Symptom Manag 23(6):501–509. https://doi.org/10.1016/S0885-3924(02)00395-0

    Article  Google Scholar 

  23. Schmidt ME, Wiskemann J, Steindorf K (2018) Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Qual Life Res 27(8):2077–2086. https://doi.org/10.1007/s11136-018-1866-8

    Article  PubMed  Google Scholar 

  24. Bernhard J, Luo W, Ribi K, Colleoni M, Burstein HJ, Tondini C, Pinotti G, Spazzapan S, Ruhstaller T, Puglisi F, Pavesi L, Parmar V, Regan MM, Pagani O, Fleming GF, Francis PA, Price KN, Coates AS, Gelber RD, Goldhirsch A, Walley BA (2015) Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials. Lancet Oncol 16(7):848–858. https://doi.org/10.1016/s1470-2045(15)00049-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Cohen PA, Brennan A, Marino JL, Saunders CM, Hickey M (2017) Managing menopausal symptoms after breast cancer—a multidisciplinary approach. Maturitas. https://doi.org/10.1016/j.maturitas.2017.04.013

    Article  PubMed  Google Scholar 

  26. Australia C (2015) Management of menopausal symptoms in women who have received breast cancer treatment. Cancer Australia, Surry Hills

    Google Scholar 

  27. Mann E, Smith MJ, Hellier J, Balabanovic JA, Hamed H, Grunfeld EA, Hunter MS (2012) Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. Lancet Oncol 13(3):309–318. https://doi.org/10.1016/s1470-2045(11)70364-3

    Article  PubMed  PubMed Central  Google Scholar 

  28. Johnson JA, Rash JA, Campbell TS, Savard J, Gehrman PR, Perlis M, Carlson LE, Garland SN (2016) A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 27:20–28. https://doi.org/10.1016/j.smrv.2015.07.001

    Article  PubMed  Google Scholar 

  29. Garland SN, Johnson JA, Savard J, Gehrman P, Perlis M, Carlson L, Campbell T (2014) Sleeping well with cancer: a systematic review of cognitive behavioral therapy for insomnia in cancer patients. Neuropsychiatr Dis Treat 10

  30. Carpenter J, Elam J, Ridner S, Carney P, Cherry G, Cucullu H (2004) Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 31:591–5598. https://doi.org/10.1188/04.ONF.591-598

    Article  PubMed  Google Scholar 

  31. Ho S-Y, Rohan KJ, Parent J, Tager FA, McKinley PS (2015) A Longitudinal study of depression, fatigue, and sleep disturbances as a symptom cluster in women with breast cancer. J Pain Symptom Manag 49(4):707–715. https://doi.org/10.1016/j.jpainsymman.2014.09.009

    Article  Google Scholar 

  32. Vincent AJ, Ranasinha S, Sayakhot P, Mansfield D, Teede HJ (2014) Sleep difficulty mediates effects of vasomotor symptoms on mood in younger breast cancer survivors. Climacteric 17(5):598–604. https://doi.org/10.3109/13697137.2014.900745

    Article  CAS  PubMed  Google Scholar 

  33. Accortt EE, Bower JE, Stanton AL, Ganz PA (2015) Depression and vasomotor symptoms in young breast cancer survivors: the mediating role of sleep disturbance. Arch Womens Ment Health 18(3):565–568. https://doi.org/10.1007/s00737-015-0504-5

    Article  PubMed  Google Scholar 

  34. Szabo RA, Marino JL, Hickey M (2019) Managing menopausal symptoms after cancer. Climacteric 22(6):572–578. https://doi.org/10.1080/13697137.2019.1646718

    Article  CAS  PubMed  Google Scholar 

  35. Melisko ME, Narus JB (2016) Sexual function in cancer survivors: updates to the NCCN guidelines for survivorship. J Natl Compr Canc Netw 14(5S):685–689. https://doi.org/10.6004/jnccn.2016.0193

    Article  PubMed  Google Scholar 

  36. Carter J, Lacchetti C, Andersen BL, Barton DL, Bolte S, Damast S, Diefenbach MA, DuHamel K, Florendo J, Ganz PA, Goldfarb S, Hallmeyer S, Kushner DM, Rowland JH (2018) Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline. J Clin Oncol 36(5):492–511. https://doi.org/10.1200/jco.2017.75.8995

    Article  PubMed  Google Scholar 

  37. Bober SL, Reese JB, Barbera L, Bradford A, Carpenter KM, Goldfarb S, Carter J (2016) How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Curr Opin Support Palliative Care 10(1):44

    Article  Google Scholar 

  38. Love RR, Cameron L, Connel BL, Leventhal H (1991) Symptoms associated with tamoxifen treatment in postmenopausal women. JAMA Intern Med 9:1842

    Article  Google Scholar 

  39. Kenne Sarenmalm E, Ohlén J, Jonsson T, Gaston-Johansson F (2007) Coping with recurrent breast cancer: predictors of distressing symptoms and health-related quality of life. J Pain Symptom Manag 34(1):24–39. https://doi.org/10.1016/j.jpainsymman.2006.10.017

    Article  Google Scholar 

  40. Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, Gralow J (2008) Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry 30(2):112–126

    Article  Google Scholar 

  41. Von Ah D, Kang D-H (2008) Correlates of mood disturbance in women with breast cancer: patterns over time. J Adv Nurs 61(6):676–689. https://doi.org/10.1111/j.1365-2648.2007.04563.x

    Article  Google Scholar 

  42. Tao XY, Zuo AZ, Wang JQ, Tao FB (2016) Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric 19(1):27–36. https://doi.org/10.3109/13697137.2015.1094784

    Article  PubMed  Google Scholar 

  43. Malek AM, Vladutiu CJ, Meyer ML, Cushman M, Newman R, Lisabeth LD, Kleindorfer D, Lakkur S, Howard VJ (2019) The association of age at menopause and all-cause and cause-specific mortality by race, postmenopausal hormone use, and smoking status. Prev Med Rep 15:100955. https://doi.org/10.1016/j.pmedr.2019.100955

    Article  PubMed  PubMed Central  Google Scholar 

  44. Hickey M, Saunders C, Partridge A, Santoro N, Stearns V, Joffe H (2008) Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol 19(10):1669–1680. https://doi.org/10.1093/annonc/mdn353

    Article  CAS  PubMed  Google Scholar 

  45. Zon RT, Frame JN, Neuss MN, Page RD, Wollins DS, Stranne S, Bosserman LD (2016) American Society of Clinical Oncology Policy Statement on Clinical Pathways in Oncology. J Oncol Pract 12(3):261–266. https://doi.org/10.1200/JOP.2015.009134

    Article  PubMed  Google Scholar 

  46. Ussher JM, Perz J, Gilbert E, Wong WKT, Mason C, Hobbs K, Kirsten L (2013) Talking about sex after cancer: a discourse analytic study of health care professional accounts of sexual communication with patients. Psychol Health 28(12):1370–1390. https://doi.org/10.1080/08870446.2013.811242

    Article  PubMed  Google Scholar 

  47. Capelan M, Battisti NML, McLoughlin A, Maidens V, Snuggs N, Slyk P, Peckitt C, Ring A (2017) The prevalence of unmet needs in 625 women living beyond a diagnosis of early breast cancer. Br J Cancer 117(8):1113–1120. https://doi.org/10.1038/bjc.2017.283

    Article  PubMed  PubMed Central  Google Scholar 

  48. Cheng KKF, Wong WH, Koh C (2016) Unmet needs mediate the relationship between symptoms and quality of life in breast cancer survivors. Support Care Cancer 24(5):2025–2033. https://doi.org/10.1007/s00520-015-2994-0

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Michelle Peate was supported by a grant from the National Breast Cancer Foundation (ECF-15-005) and is currently supported by a Department of Obstetrics and Gynaecology, University of Melbourne Fellowship. Martha Hickey is supported by a Practitioner Fellowship from the National Health and Medical Research Council (APP1058945). We acknowledge the assistance of Breast Cancer Network Australia (BCNA) and the BCNA Review & Survey Group which was invaluable in undertaking this research.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michelle Peate.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Ethical approval

Approval was obtained from the ethics committee of Royal Women’s Hospital Ethics Committee (Project AQA 20/43). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary information 1 (DOCX 60 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peate, M., Saunders, C., Cohen, P. et al. Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors. Breast Cancer Res Treat 187, 427–435 (2021). https://doi.org/10.1007/s10549-021-06117-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-021-06117-7

Keywords

Navigation